Cardiac Biomarker in Pediatric Heart Disease

The recruitment status of this study is unknown because the information has not been verified recently.
Verified April 2013 by Okayama University.
Recruitment status was  Recruiting
Information provided by (Responsible Party):
Tomoyuki Kanazawa, Okayama University Identifier:
First received: April 15, 2013
Last updated: April 17, 2013
Last verified: April 2013

The purpose of this study is to investigate cardiac biomarker during perioperative management in pediatric cardiac surgery.

Congenital Heart Disease

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Observational Study of Cardiac Biomarker During Perioperative Management in Pediatric Heart Disease

Resource links provided by NLM:

Further study details as provided by Okayama University:

Primary Outcome Measures:
  • serious adverse events [ Time Frame: one month ] [ Designated as safety issue: Yes ]

Biospecimen Retention:   Samples With DNA


Estimated Enrollment: 150
Study Start Date: November 2012
Estimated Study Completion Date: December 2014
Estimated Primary Completion Date: November 2014 (Final data collection date for primary outcome measure)

Ages Eligible for Study:   up to 18 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

pediatric patients who receive surgery for congenital heart disease under 18 years old


Inclusion Criteria:

  • children who receive surgery for congenital heart disease
  • require cardiopulmonary bypass for surgery
  • under 18 years old

Exclusion Criteria:

  • simple congenital heart disease (atrial septal defect, ventricle septal defect, patent ductus arteriosus)
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01834976

Contact: TOMOYUKI KANAZAWA +81862357778
Contact: MORITOKI EGI +81862357778

Okayama University Hospital Recruiting
Okayama, Japan, 7008558
Contact: TOMOYUKI KANAZAWA    +81862357778   
Contact: MORITOKI EGI    +81862357778   
Sponsors and Collaborators
Okayama University
  More Information

No publications provided

Responsible Party: Tomoyuki Kanazawa, Pediatric cardiac surgery investigators, Okayama University Identifier: NCT01834976     History of Changes
Other Study ID Numbers: pchd biomarker in okayama
Study First Received: April 15, 2013
Last Updated: April 17, 2013
Health Authority: Japan: Ministry of Education, Culture, Sports, Science and Technology

Keywords provided by Okayama University:
cardiac biomarker
congenital heart disease

Additional relevant MeSH terms:
Heart Defects, Congenital
Heart Diseases
Cardiovascular Abnormalities
Cardiovascular Diseases
Congenital Abnormalities processed this record on October 07, 2015